Skip to main content

#153765

Family 1 father – LAD-III Lymphoblastoid Cell Line

Cat. #153765

Family 1 father – LAD-III Lymphoblastoid Cell Line

Cat. #: 153765

Unit size: 1x10^6 cells / vial

Availability: 8-10 weeks

Organism: Human

Tissue: Blood

Disease: Cancer

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Nancy Hogg

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Family 1 father – LAD-III Lymphoblastoid Cell Line
  • Alternate name: Fermitin family homolog 3, MIG2-like protein, Unc-112-related protein 2
  • Cancer: Blood cancer
  • Cancers detailed: Leukocyte Adhesion Deficiency-III (LAD-III)
  • Research fields: Cell biology;Immunology
  • Organism: Human
  • Tissue: Blood
  • Disease: Cancer
  • Growth properties: Suspension, lymphoblastoid cell line
  • Description: An EBV-transformed B lymphoblastoid cell line (LCL) derived from the father of a Maltese subject that has Leukocyte Adhesion Deficiency-III (LAD-III) with a mutation in the kindlin-3 gene. LCLs are also available from the subject, mother and subject's sister. This cell line was derived from 'Family 1 father' as described in Svensson et al. 2009. N.Nat Med. 2009 Mar;15(3):306-12. PMID: 1923446
  • Biosafety level: 1

Target Details

  • Target: Kindlin-3, UniProt ID:Q86UX7

Handling

  • Format: Frozen
  • Growth medium: RPMI-1640 + 10% FCS
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Storage conditions: Liquid Nitrogen
  • Mycoplasma free: Yes

Related Tools

  • Related tools: Family 1 subject - LAD-III Lymphoblastoid Cell Line ; Family 1 mother - LAD-III Lymphoblastoid Cell Line ; Family 1 sibling - LAD-III Lymphoblastoid Cell Line

References

  • Svensson et al. 2009. Nat Med. 15(3):306-12. PMID: 19234463.
  • Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.